Skip to main navigation Skip to search Skip to main content

Thalidomide and lenalidomide for treatment of primary myelofibrosis

  • Roswell Park Cancer Institute
  • SUNY Buffalo

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Original languageEnglish
Title of host publicationImmunomodulating Drugs for the Treatment of Cancer
PublisherWolters Kluwer Health Adis (ESP)
ISBN (Electronic)9781451153613
ISBN (Print)9781605473338
StatePublished - Mar 29 2012

Fingerprint

Dive into the research topics of 'Thalidomide and lenalidomide for treatment of primary myelofibrosis'. Together they form a unique fingerprint.

Cite this